论文部分内容阅读
目的探讨门冬氨酸钾镁治疗小儿心律失常的临床疗效。方法选择景德镇市妇幼保健院儿科2013年1月—2015年12月收治的心律失常患儿42例,按照治疗方法不同分为对照组和观察组,各21例。对照组采用常规治疗,观察组在对照组基础上应用门冬氨酸钾镁治疗,比较两组患儿的临床疗效及治疗前后的期前收缩次数。结果观察组患儿治疗总有效率为80.9%(17/21),高于对照组的52.4%(11/21),差异有统计学意义(P<0.05)。治疗前两组患儿平均期前收缩次数比较,差异无统计学意义(P>0.05)。治疗后两组患儿平均期前收缩次数低于治疗前,差异有统计学意义(P<0.05);且观察组平均期前收缩次数低于对照组,差异有统计学意义(P<0.05)。结论门冬氨酸钾镁治疗小儿心律失常疗效良好,极大提高了治疗有效率,也可有效控制患儿的临床症状,值得大力推广。
Objective To investigate the clinical efficacy of potassium-magnesium aspartate in the treatment of children with arrhythmia. Methods Forty-two children with arrhythmia admitted from January 2013 to December 2015 in Jingdezhen Maternal and Child Health Care Hospital were divided into control group and observation group, 21 cases in each group. The control group was treated with conventional therapy. The observation group was treated with potassium-magnesium aspartate on the basis of the control group. The clinical efficacy and the number of pre-term contractions in both groups were compared. Results The total effective rate of observation group was 80.9% (17/21), which was higher than that of control group (52.4%, 11/21), the difference was statistically significant (P <0.05). The mean systolic frequency of the two groups before treatment was no significant difference (P> 0.05). The mean systolic frequency of the two groups after treatment was lower than that before treatment (P <0.05), and the mean systolic frequency of the observation group was lower than that of the control group (P <0.05) . Conclusion Potassium and magnesium aspartate treatment of children with arrhythmia good effect, which greatly improves the treatment efficiency, but also can effectively control the clinical symptoms of children, it is worth promoting.